CURIS, INC. Accumulated Other Comprehensive Income
CURIS, INC. (CRIS) had Accumulated Other Comprehensive Income of $0 as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2025-03-31
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2024-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $42.00K.
- 2024-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $338.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-31 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $42.00K 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $338.00K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $229.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $103.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $2.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $9.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | -$186.00K 10-K · filed 2024-02-08 | |
| 2022-09-30 | -$479.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$555.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | -$451.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | -$109.00K 10-K · filed 2023-03-13 | |
| 2021-09-30 | -$3.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$3.00K 10-Q · filed 2021-08-03 | |
| 2021-03-31 | -$9.00K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | -$3.00K 10-K · filed 2022-02-24 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-16 | |
| 2019-09-30 | $3.00K 10-Q · filed 2019-11-05 | |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-05 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 | |
| 2018-06-30 | -$1.00K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | -$6.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | -$2.00K 10-K · filed 2019-03-26 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$3.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | -$6.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | -$4.00K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $26.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $57.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $59.55K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $28.00K 10-K · filed 2017-03-09 | $27.77K 10-K · filed 2016-02-29 |
| 2015-09-30 | $53.51K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$1.58K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | -$2.40K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$11.00K 10-K · filed 2016-02-29 | |
| 2014-09-30 | $3.46K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $7.40K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$2.75K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | -$6.98K 10-K · filed 2015-02-24 | |
| 2013-09-30 | $14.13K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $8.92K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $14.10K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $15.16K 10-K · filed 2014-03-13 | |
| 2012-09-30 | $23.72K 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $39.72K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $52.50K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $33.97K 10-K · filed 2013-03-13 | |
| 2011-09-30 | $22.73K 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $33.70K 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $45.36K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |